This binding triggers a cascade of cellular responses that stimulate the release of growth hormone (GH) from the pituitary gland, which subsequently increases circulating insulin-like growth factor-1 (IGF-1) levels
It is not simply a "stronger ghrelin receptor agonist"
Here are some of the most surprising and significant benefits of GLP-1s that are reshaping modern medicine
Ongoing clinical trials are investigating the anti-cancer potential of sulfasalazine in metastatic colorectal cancer (NCT06134388), breast cancer (NCT03847311), and acute myeloid leukemia (NCT05580861)
Only freeze lyophilized (powder) vials
1 DKD occurs in 25 to 40% of people with type 1 or type 2 diabetes who also have risk factors, including hyperglycaemia, hypertension, a history or current habit of smoking, poor plasma lipid control and a genetic predisposition